Key result
Severe pre-implantation hyponatremia was associated with an increased risk of death compared to normal sodium in patients undergoing ICD implantation.
Why the study?
Does pre-implantation hyponatremia predict death, acute decompensated heart failure, and appropriate ICD therapy in patients with left ventricular dysfunction undergoing ICD implantation?
Cohort (n=911)
Does pre-implantation hyponatremia predict death, acute decompensated heart failure, and appropriate ICD therapy in patients with left ventricular dysfunction undergoing ICD implantation?
Pre-implantation hyponatremia in ICD recipients with left ventricular dysfunction is a strong predictor of increased mortality and heart failure morbidity, but is associated with a reduced incidence of appropriate ICD therapy.
Answers are grounded in this paper and cite their sources.
Severe hyponatremia may flag higher mortality risk before ICD implantation; leaves open whether correction improves outcomes.
AIMS: Hyponatremia is commonly observed among patients with left ventricular (LV) dysfunction and is a marker for adverse outcomes. We aimed to determine the prognostic significance of pre-implant hyponatremia on the outcomes of death, acute decompensated heart failure (ADHF) and appropriate implantable cardioverter-defibrillator (ICD) therapy for ventricular arrhythmias among patients with ICDs. METHODS AND RESULTS: The study population consisted of patients with an ejection fraction ≤40% undergoing ICD implantation (n = 911) for the primary or secondary prevention of sudden cardiac death from 1997 to 2007. The predictive value of the severity of pre-implantation hyponatremia stratified into mild hyponatremia (n = 268, sodium 134-136 mmol/L), moderate hyponatremia (n = 105, sodium 131-133 mmol/L), and severe hyponatremia (n = 31, sodium ≤130 mmol/L) on the risk of death, ADHF, and appropriate ICD therapy for ventricular arrhythmias as compared with patients a normal serum sodium (n = 507, sodium ≥ 137 mmol/L), was calculated using multivariable Cox proportional hazards analyses. During a mean follow-up of 775 ± 750 days as the severity of hyponatremia (from a normal sodium to severe hyponatremia) increased an incremental incidence of death (25% to 61%, P < 0.001) and ADHF (11% to 26%, P = 0.004) was observed with a reduced incidence of ICD therapy for ventricular tachycardia/ventricular fibrillation (37-29%, P = 0.037). Compared with the normal sodium cohort, patients with severe hyponatremia demonstrated an increased risk of death [adjusted hazard ratio (AHR) 2.69 (95% confidence interval, CI 1.57-4.59), P = 0.004] and ADHF [AHR 2.98 (95% CI 1.41-6.30), P = 0.004], with a lower probability of appropriate ICD therapy [AHR 0.68 (95% CI 0.27-0.88), P = 0.031]. CONCLUSION: Hyponatremia is commonly observed among ICD recipients with LV dysfunction. Patients with an increasing severity of hyponatremia are at increased risk of death and HF related morbidity with a reduced incidence of appropriate ICD therapy particularly among patients with severe hyponatremia.
No takes yet. Share an insight, caveat, or question.
Bhavnani et al. (2013) conducted a cohort in Left ventricular dysfunction and implantable cardioverter-defibrillators (n=911). Severe hyponatremia (sodium ≤130 mmol/L) vs. Normal serum sodium (≥ 137 mmol/L) was evaluated on Death (AHR 2.69, 95% CI 1.57-4.59, p=0.004). Severe pre-implantation hyponatremia was associated with an increased risk of death compared to normal sodium in patients undergoing ICD implantation.
Synapse has enriched 10 related papers. Consider them for comparative context: